Site 02: Accelovance — Peoria, Illinois

Site 02: Accelovance is a clinical research site located in Peoria, Illinois, United States 61602.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 02: Accelovance has participated in 1 clinical trials.

Therapeutic areas: H7N9 Influenza.

Sponsors: Novartis Vaccines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Peoria

Browse all research sites in Illinois · View every site in Peoria

• Bradley University
• University of Illinois at Peoria
• University of Illinois College of Medicine
• St. Francis Hospital
• University of Illinois School of Medicine
• Children's Hospital of Illinois at OSF-Saint Francis Medical Center
• University of Illinois College of Medicine at Peoria
• University of Illinois College of Medicine at Peoria Pediatric Subspecialty Clinic
• Carle Health Methodist Hospital
• Saint Francis Medical Center/ Children's Hospital of Illinois/OSF
• St. Jude Children's Research Hospital
• Children's Hospital of Illinois at OSF Saint Francis Medical Center, Cystic Fibrosis Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 02: Accelovance?

Site 02: Accelovance has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 02: Accelovance conducted?

Site 02: Accelovance has 1 clinical trials on record. Their work covers H7N9 Influenza.

Is Site 02: Accelovance accredited by Crixeo Clinical Trials?

Site 02: Accelovance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 02: Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.